Skip to content

A randomized-control multi-centres study on the safety & effectiveness of peri-operative transfusion trigger score (POTTS)

A randomized-control multi-centres study on the safety & effectiveness of peri-operative transfusion trigger score (POTTS)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004478
Enrollment
Unknown
Registered
2014-04-10
Start date
2014-02-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective surgery with potential massive blood loss requiring blood transfusion

Interventions

Three groups:1. transfusion to keep Hb more than 10g/dL , 2. transfusion based on clinicians' discretion when Hb between 7-10g/dL
and 3. POTTS group, during Intra-operative and post-operative period

Sponsors

Prince of Wales Hospital, Shatin, Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age older than 14 weeks old; 2. Live in an area of altitude shorter than 2500 m most of the time; 3. Estimated intraoperative blood loss more than 1000ml, or more than 20% of total blood volume.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Patients with physical status of ASA class V or above; 3. Patients with known severe haematological disorders; 4. Patients with known haemaglobinopathy; 5. Acute hypervolemic haemodilution is planned; 6. Patients with known metastatic cancer or more than one neoplasm concurrently; 7. Other conditions that may preclude the patients from the study, such as language barrier, psychiatric disorders, unable to attend research center for follow up; 8. Patients who enrolled to another research study or are taking experimental medication in last 3 months prior to this study; 9. Not suitable for the study, after assessment by the investigators.

Design outcomes

Primary

MeasureTime frame
1 Incidence of patients required blood transfusion and the unit number of blood transfused.;2 Mortality rate and incidence of serious complications.;3 Five-year in remission survival rate after hospital discharge and overall survival rate.;

Secondary

MeasureTime frame
1. Intensive Care Unit (ICU) admission rate and ICU length of stay (LOS);;2. Post-operative Hb level;;3. Surgical wound complication rate;;4. Hospital length of stay;;5. Transfusion-related cost and hospital admission cost;;6. Post-operative quality of life.;

Countries

China

Contacts

Public ContactMs Winnie Samy
wsamy@cuhk.edu.hk+852 2632 2735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026